NDC 68071-3808-01 - Phentermine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3808
- Requested NDC
- 68071-3808-01
- Package NDCs from labels
- 68071-3808-1, 68071-3808-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2025-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phentermine Hydrochloride - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2025-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3808-1 | Phentermine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3808 | PHENTERMINE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Current NDC, 1 package rows | 20250322_30b48126-45f3-21fa-e063-6294a90a968f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 70bc6f36-8087-4ccd-a396-a911c0ebae79 | 2026-08-17 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine hydrochloride | PHENTERMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 129e781c-5366-4986-8e67-6b35fa4c3f39 | 2026-08-17 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | d77f31b4-7e36-4a0a-a55b-78b4b6ab5cb7 | 2026-08-17 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Northwind Health Company, LLC | 5528d9f7-45ad-d323-e063-6394a90a3e09 | 2026-06-25 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | Aurolife Pharma LLC | 5927e0f6-3de3-4885-a633-5b92003f6fe4 | 2026-06-10 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 19f1ce79-65f4-4bf4-a9ff-6ca0a131530f | 2026-06-02 | Warnings, Adverse reactions | ANDA200272 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 130e6087-0ab6-4456-a781-d370f363dc38 | 2026-06-01 | Warnings, Adverse reactions | 0K2I505OTV |
| LOMAIRA | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 0718f0f3-77f2-45d7-be12-1ed718c8b806 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | d24aaa53-9c78-4c1b-9495-c785a9cf2b26 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 2f3b738f-d66b-40c1-8e69-bcd50bce3e47 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 27e88ebe-6247-4598-8ef2-c882992ed579 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine hydrochloride | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 3d1d4dde-1c7f-4a20-b8f8-897b1b284f80 | 2026-05-21 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| phentermine and topiramate | PHENTERMINE AND TOPIRAMATE | Prasco Laboratories | 876bd763-13fa-481e-b579-c2fc44dbf3c2 | 2026-05-18 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | d95e14f7-a46d-47fa-8dab-ee3d8d4c7b6d | 2026-05-12 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | e6939fcf-3db2-492a-99ed-a384cdeea7a2 | 2026-05-11 | Warnings, Adverse reactions | ANDA200272 803353 0K2I505OTV |
| Qsymia | PHENTERMINE AND TOPIRAMATE | Vivus LLC | 40dd5602-53da-45ac-bb4b-15789aba40f9 | 2026-04-22 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | eae1d7f9-733c-434b-9199-5f7052e541da | 2026-04-14 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | 328d6a39-34f4-4b74-a1bf-6ec6005b1322 | 2026-04-01 | Warnings, Adverse reactions | ANDA200272 803353 0K2I505OTV |
| Phentermine and Topiramate Extended-Release | PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE | Dr.Reddys Laboratories Inc | 260c3f90-163d-0bdd-1099-55d18a900e68 | 2026-03-31 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | b425840f-380e-42bd-852a-6ee3641977ce | 2026-03-23 | Warnings, Adverse reactions | 0K2I505OTV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.